Table 3.
Baseline characteristics between MVI positivity and MVI negativity groups
| Variables | MVI positivity (n=192) | MVI negativity (n=141) |
|---|---|---|
| Age (range) (years) | 48 (29–71) | 48 (29–79) |
| Sex, male/female | 162/30 | 122/19 |
| HBsAg, positive/negative | 164/28 | 124/17 |
| HBV DNA (copies/mL), >500/≤500 | 138/54 | 94/47 |
| AFP (ng/mL), >400/≤400 | 109/83 | 56/85 |
| Tumor size (cm), >5/≤5 | 139/53 | 56/85 |
| Edmondson stage, low/high | 126/66 | 97/34 |
| Node number, single/multiple | 129/63 | 106/35 |
| Capsule, incomplete/complete | 66/126 | 18/123 |
| Cirrhosis, low/high | 133/59 | 89/52 |
| KI-67 expression, high/low | 105/87 | 32/109 |
Abbreviations: AFP, alpha-fetoprotein; HBsAg, serum hepatitis B surface antigen; HBV DNA, hepatitis B virus DNA levels; MVI, microvascular invasion.